Skip to search formSkip to main contentSkip to account menu

ibudilast

Known as: Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-, Ibudilastum, 3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Neuroinflammatory signaling pathways in the central nervous system are of current interest as potential pharmacotherapy targets… 
Review
2009
Review
2009
Ibudilast is a relatively nonselective phosphodiesterase inhibitor which has been marketed for almost 20 years in Japan for… 
Review
2007
Review
2007
The treatment of neuropathic pain is a major unresolved medical challenge. Present pharmacotherapies only have modest efficacy… 
2005
2005
BackgroundTwitcher mouse (twi/twi) is an authentic murine model of Krabbe's disease. Accumulation of psychosine, resulting in… 
Highly Cited
2004
Highly Cited
2004
We investigated the immunoregulatory effects of ibudilast, a nonselective phosphodiesterase inhibitor, at a clinically applicable… 
2001
2001
We examined the effect of 3‐isobutyryl‐2‐isopropylpyrazolo[1,5‐a]pyridine (ibudilast), which has been clinically used for… 
Highly Cited
1992
Highly Cited
1992
Ibudilast, a unique agent with vasodilating and antiallergic actions, was studied in 13 asthmatics for its effect on airway…